iSpecimen Inc. Shareholders' Equity
iSpecimen Inc. (ISPC) had Shareholders' Equity of $1.74 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $1.74M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $814.04K.
- 2025-12-31: Stockholders' Equity Attributable to Parent $3.09M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $3.07M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $1.74M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $814.04K 10-Q · filed 2026-08-14 |
| 2025-12-31 | $3.09M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $3.07M 10-Q · filed 2025-11-17 |
| 2025-06-30 | $621.97K 10-Q · filed 2026-08-14 |
| 2025-03-31 | $1.67M 10-Q · filed 2026-08-14 |
| 2024-12-31 | $3.31M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $4.71M 10-Q · filed 2025-11-17 |
| 2024-06-30 | $6.09M 10-Q · filed 2025-11-17 |
| 2024-03-31 | $6.81M 10-Q · filed 2025-11-17 |
| 2023-12-31 | $9.74M 10-K · filed 2026-04-01 |
| 2023-09-30 | $12.71M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $14.71M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $18.08M 10-Q · filed 2024-11-07 |
| 2022-12-31 | $20.31M 10-K · filed 2025-04-14 |
| 2022-09-30 | $22.42M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $25.30M 10-Q · filed 2023-11-02 |
| 2022-03-31 | $27.67M 10-Q · filed 2023-11-02 |
| 2021-12-31 | $29.79M 10-K · filed 2024-03-13 |
| 2021-09-30 | $12.09M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $10.68M 10-Q · filed 2022-11-08 |
| 2021-03-31 | -$31.22M 10-Q · filed 2022-11-08 |
| 2020-12-31 | -$27.28M 10-K/A · filed 2023-03-30 |
| 2020-09-30 | -$25.70M 10-Q · filed 2021-11-04 |
| 2020-06-30 | -$24.48M 10-Q · filed 2021-11-04 |
| 2020-03-31 | -$24.33M 10-Q · filed 2021-11-04 |
| 2019-12-31 | -$22.72M 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |